Security key
16385C104
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB)
CUSIP: 16385C104
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Ordinary Shares / American Depositary Shares
- Total 13F shares
- 4,549,767
- Total 13F value
- $7,142,810
- Share change
- +1,877,011
- SEC-reported price per share
- $1.57
- Number of holders
- 15
- Value change
- +$3,023,403
- Number of buys
- 10
- Number of sells
- 7
- Shares outstanding
- 412,914,375
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
15
Top holders
10
CMMB full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Chemomab Therapeutics Ltd. SEC filings
Chemomab Therapeutics Ltd. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 16385C104
Recent filing periods:
Ownership snapshot
Top reported holders of CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Novo Holdings A/S
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 33%
Showing 1-6 of 15 holder rows.
Quick read
Novo Holdings A/S leads the comparable SEC ownership view at 33%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Novo Holdings A/S's linked filing trail.
Comparable ownership
Top 5
Novo Holdings A/S
33%
RENAISSANCE TECHNOLOGIES LLC
7.7%
VANGUARD GROUP INC
2.9%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
2.2%
STATE STREET CORP
0.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Novo Holdings A/S |
13F
Company
|
33%
|
$1,183,953
2,497,791 shares
|
— | 30 Jun 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
7.7%
|
$274,762
579,300 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
2.9%
|
$104,915
221,200 shares
|
— | 30 Jun 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
2.2%
|
$79,849
168,352 shares
|
— | 30 Jun 2024 |
| STATE STREET CORP |
13F
Company
|
0.6%
|
$21,299
44,906 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
Company
|
0.54%
|
$2,045,162
2,241,273 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
4,549,767
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
15
Q3 2024 holders
15
Holder diff
0
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend